Vials are inspected at Regeneron Pharmaceuticals’ facilities in New York. Photo: Regeneron handout via AP
Vials are inspected at Regeneron Pharmaceuticals’ facilities in New York. Photo: Regeneron handout via AP

Coronavirus: Regeneron’s antiviral cocktail reduces viral load and need for medical care, trial shows

  • Patients on therapy, which US President Donald Trump also received, were 57 per cent less likely to need medical care within month of treatment
  • Cocktail appears to be most potent for those at higher risk, including older patients and those with other medical conditions

Vials are inspected at Regeneron Pharmaceuticals’ facilities in New York. Photo: Regeneron handout via AP
Vials are inspected at Regeneron Pharmaceuticals’ facilities in New York. Photo: Regeneron handout via AP
READ FULL ARTICLE